Cell Signaling and Drug Discovery Group (Waaler)
Company

Cell Signaling and Drug Discovery Group (Waaler)

Biotechnology Research Oslo, No 6 employees IMMX
Employees
6

Cell Signaling and Drug Discovery Group (Waaler) Overview

Headquarters
Oslo, No
Industry
Biotechnology Research
Employees
6
Stock Symbol
IMMX
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Cell Signaling and Drug Discovery Group (Waaler)

Our research group at Oslo University Hospital is dedicated to advancing the understanding of tankyrase 1 and tankyrase 2 (TNKS1/2), key enzymes in the PARP family that regulate protein function, interactions, and degradation through ADP-ribosylation and downstream signaling. TNKS1/2 play crucial roles in controlling WNT/β-catenin and Hippo signaling pathways, both of which are central to disease mechanisms such as cancer, immune evasion, and fibrosis.

Compare Similar Companies to Cell Signaling and Drug Discovery Group (Waaler)